JP2005532254A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005532254A5 JP2005532254A5 JP2003541765A JP2003541765A JP2005532254A5 JP 2005532254 A5 JP2005532254 A5 JP 2005532254A5 JP 2003541765 A JP2003541765 A JP 2003541765A JP 2003541765 A JP2003541765 A JP 2003541765A JP 2005532254 A5 JP2005532254 A5 JP 2005532254A5
- Authority
- JP
- Japan
- Prior art keywords
- uridine
- tetraphosphate
- triphosphate
- alkyl
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33782801P | 2001-11-06 | 2001-11-06 | |
| PCT/US2002/035775 WO2003039473A2 (en) | 2001-11-06 | 2002-11-06 | Method for treating or preventing inflammatory diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005532254A JP2005532254A (ja) | 2005-10-27 |
| JP2005532254A5 true JP2005532254A5 (enExample) | 2006-01-05 |
Family
ID=23322192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003541765A Pending JP2005532254A (ja) | 2001-11-06 | 2002-11-06 | 炎症性疾患を治療又は予防する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7256183B2 (enExample) |
| EP (1) | EP1450820A4 (enExample) |
| JP (1) | JP2005532254A (enExample) |
| KR (1) | KR20050043761A (enExample) |
| CN (1) | CN1612739A (enExample) |
| AR (1) | AR037263A1 (enExample) |
| BR (1) | BR0213897A (enExample) |
| CA (1) | CA2465894A1 (enExample) |
| MX (1) | MXPA04004215A (enExample) |
| TW (1) | TW200300692A (enExample) |
| WO (1) | WO2003039473A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003028712A2 (en) * | 2001-09-28 | 2003-04-10 | Universite Libre De Bruxelles | Purinergic and pyrimidinergic receptor agonists for the treatment of activated cd4+ t lymphocyte-mediated immune diseases |
| US20060177517A1 (en) * | 2003-02-26 | 2006-08-10 | Toshikazu Shiba | Antiinflammtory agent and antiinflammatory medical material |
| GB0417886D0 (en) * | 2004-08-11 | 2004-09-15 | Univ Cardiff | Method and means for enhanced pulmonary delivery |
| SE529064C2 (sv) * | 2005-01-03 | 2007-04-24 | Selectica Pharmaceuticals Ab | Topiska kompositioner |
| GB0502250D0 (en) * | 2005-02-03 | 2005-03-09 | Ic Vec Ltd | Use |
| WO2007041495A2 (en) * | 2005-09-29 | 2007-04-12 | University Of California, San Diego | Dampening humoral and innate immunity by inhibition of ppgalnact-1 |
| US8618074B2 (en) * | 2007-03-15 | 2013-12-31 | Board Of Regents Of The University Of Texas System | GPCR enhanced neuroprotection to treat brain injury |
| US8168597B2 (en) * | 2008-10-22 | 2012-05-01 | Inspire Pharmaceuticals, Inc. | Method for treating cystic fibrosis |
| GB201209244D0 (en) * | 2012-05-25 | 2012-07-04 | Globalacorn Ltd | Compositions |
| US10111904B2 (en) * | 2013-01-09 | 2018-10-30 | Berlock Aps | Micron-sized gold, kit comprising said gold and its use as a non-toxic immune suppressor |
| US20150031712A1 (en) * | 2013-03-12 | 2015-01-29 | Moshe Rogosnitzky | Therapeutic Compositions Containing Dipyridamole and Treatment Packs Including Such Compositions and Methods for Producing Same |
| GB201320962D0 (en) * | 2013-11-27 | 2014-01-08 | Globalacorn Ltd | Compositions |
| GB201320959D0 (en) * | 2013-11-27 | 2014-01-08 | Globalacorn Ltd | Compositions |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5292498A (en) | 1991-06-19 | 1994-03-08 | The University Of North Carolina At Chapel Hill | Method of treating lung disease with uridine triphosphates |
| US6255059B1 (en) | 1993-03-31 | 2001-07-03 | Cadus Pharmaceutical Corporation | Methods for identifying G protein coupled receptor effectors |
| US5656256A (en) | 1994-12-14 | 1997-08-12 | The University Of North Carolina At Chapel Hill | Methods of treating lung disease by an aerosol containing benzamil or phenamil |
| US6147056A (en) * | 1995-06-06 | 2000-11-14 | Trustees Of Boston University | Use of locally applied DNA fragments |
| US5635160A (en) | 1995-06-07 | 1997-06-03 | The University Of North Carolina At Chapel Hill | Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions |
| US5628984A (en) | 1995-07-31 | 1997-05-13 | University Of North Carolina At Chapel Hill | Method of detecting lung disease |
| US6423694B1 (en) | 1996-02-21 | 2002-07-23 | Inspire Pharmaceuticals, Inc. | Method of treating otitis media with uridine triphosphates and related compounds |
| US5900407A (en) | 1997-02-06 | 1999-05-04 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with uridine triphosphates and related compounds |
| AU727314B2 (en) | 1996-03-27 | 2000-12-07 | Inspire Pharmaceuticals, Inc. | Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| US5837861A (en) | 1997-02-10 | 1998-11-17 | Inspire Pharmaceuticals, Inc. | Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
| US5789391A (en) | 1996-07-03 | 1998-08-04 | Inspire Pharmaceuticals, Inc. | Method of treating sinusitis with uridine triphosphates and related compounds |
| US5968913A (en) | 1996-07-03 | 1999-10-19 | Inspire Pharmaceuticals, Inc. | Pharmaceutical compositions of uridine triphosphate |
| US5763447C1 (en) | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
| WO1998015835A1 (en) | 1996-10-08 | 1998-04-16 | Inspire Pharmaceuticals, Inc. | Method of early lung cancer detection via sputum induction and analysis of sputum to detect cancer associated substances |
| EP0929218A4 (en) * | 1996-10-30 | 2001-05-16 | Univ North Carolina | P2Y RECEPTOR ANTAGONISTS |
| US6159952A (en) | 1996-11-07 | 2000-12-12 | Inspire Pharmaceuticals, Inc. | Method of treating bronchitis with uridine triphosphate and related compounds |
| ES2264197T3 (es) * | 1997-02-06 | 2006-12-16 | Inspire Pharmaceuticals, Inc. | Dinucleotidos y sus usos. |
| US6372724B1 (en) * | 1997-03-25 | 2002-04-16 | Duska Scientific Co. | Modulation of human mast cell activation |
| US6462028B2 (en) | 1997-07-25 | 2002-10-08 | Inspire Pharmaceuticals, Inc. | Method of promoting cervical and vaginal secretions |
| US6143279A (en) * | 1997-08-29 | 2000-11-07 | The University Of North Carolina At Chapel Hill | Uridine 5'-diphosphate and analogs useful for treating lung diseases |
| JP4633927B2 (ja) * | 1998-05-22 | 2011-02-16 | インスパイアー ファーマシューティカルズ，インコーポレイティド | 治療用ジヌクレオチドおよび誘導体 |
| US6264975B1 (en) * | 1998-10-20 | 2001-07-24 | The University Of North Carolina At Chapel Hill | Methods of hydrating mucosal surfaces |
| WO2000050024A2 (en) * | 1999-02-26 | 2000-08-31 | Inspire Pharmaceuticals, Inc. | Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof |
| CN1413113A (zh) * | 1999-12-22 | 2003-04-23 | 印斯拜尔药品股份有限公司 | 使用嘌呤能受体激动剂治疗胃肠道疾病的方法 |
| US6610274B1 (en) * | 2000-12-22 | 2003-08-26 | Wallace J. Gardner | Anti-inflammatory composition comprising tetracycline |
| EP1432426A2 (en) * | 2001-09-05 | 2004-06-30 | ACTIAL Farmaceutica Lda. | USE OF UNMETHYLATED CpG |
-
2002
- 2002-11-06 CN CNA028267281A patent/CN1612739A/zh active Pending
- 2002-11-06 TW TW091132682A patent/TW200300692A/zh unknown
- 2002-11-06 EP EP02789499A patent/EP1450820A4/en not_active Withdrawn
- 2002-11-06 AR ARP020104238A patent/AR037263A1/es unknown
- 2002-11-06 MX MXPA04004215A patent/MXPA04004215A/es active IP Right Grant
- 2002-11-06 WO PCT/US2002/035775 patent/WO2003039473A2/en not_active Ceased
- 2002-11-06 BR BRPI0213897-2A patent/BR0213897A/pt not_active IP Right Cessation
- 2002-11-06 JP JP2003541765A patent/JP2005532254A/ja active Pending
- 2002-11-06 KR KR1020047006855A patent/KR20050043761A/ko not_active Withdrawn
- 2002-11-06 CA CA002465894A patent/CA2465894A1/en not_active Abandoned
- 2002-11-06 US US10/290,213 patent/US7256183B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100587747B1 (ko) | Ｃ형 간염 바이러스에 의해 매개되는 질환의 치료를 위한4'-치환된 뉴클레오시드 | |
| AU2003217863B2 (en) | Nucleotide mimics and their prodrugs | |
| EP2696679B1 (en) | 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
| CA2812962C (en) | Azido nucleosides and nucleotide analogs | |
| CA2279963C (en) | Dinucleotides and their use | |
| EP2697242B1 (en) | 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases | |
| CN100457118C (zh) | 用于治疗肝炎病毒感染的3′-或2′-羟甲基取代的核苷衍生物 | |
| JP2005015491A5 (enExample) | ||
| KR20030061792A (ko) | 뉴클레오시드 유도체 | |
| PT1937825T (pt) | 4¿-nucleósidos modificados como agentes antivirais | |
| JP2005532254A5 (enExample) | ||
| JP2005508297A5 (enExample) | ||
| WO2004080466A1 (en) | Cytidine analogs and methods of use | |
| AU2010226466A1 (en) | Substituted nucleoside and nucleotide analogs | |
| EP1478322A2 (en) | Beta-2'-OR 3'-HALONUCLEOSIDES | |
| CN116036114A (zh) | 用于rna病毒治疗的2’-取代的-n6-取代的嘌呤核苷酸 | |
| KR102573609B1 (ko) | 호흡기 세포융합 바이러스 rna 복제 억제제로서의 4'-비닐 치환된 뉴클레오시드 유도체 | |
| WO2016115222A1 (en) | 4'-azido substituted nucleoside derivatives as inhibitors of ebola virus rna replication | |
| JP2003511454A (ja) | ピロロ［２，３−ｄ］ピリミジンヌクレオシド類似化合物 | |
| JPH02180894A (ja) | 抗ウイルス剤 | |
| WO2006016115A2 (en) | Method and means for enhanced pulmonary drug delivery |